Canada · Health Canada Drug Product Database

POLIOVIRUS VACCINE LIVE ORAL TRIVALENT

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 670
DIN: 00075043
Form: Suspension
Company as listed by source: AVENTIS PASTEUR LIMITED
Source status: Cancelled Post Market (2000-04-06)
Source last updated: 2025-03-22

Source-listed ingredients

POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 — 1000000 UNIT — per 1 DOSE
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 — 100000 UNIT — per 1 DOSE
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 — 300000 UNIT — per 1 DOSE

These values do not establish equivalence or a dose recommendation.

Packages

1/10/20/50doses

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →